Chai, Sanbao

Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis

Sun, F., Wu, S., Wang, J., Guo, S., Chai, S., Yang, Z., Li, L., Zhang, Y., Ji, L., & Zhan, S. (2015) · Clinical Therapeutics

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 232

Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

Sun, F., Chai, S., Yu, K., Quan, X., Yang, Z., Wu, S., Zhang, Y., Ji, L., Wang, J., & Shi, L. (2015) · Diabetes Technology & Therapeutics

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 158

A Novel Risk Score Model for the Differential Diagnosis of Type 2 Diabetic Nephropathy: A Multicenter Study

Zhao, Y., Liu, L., Zuo, L., Zhou, X., Wang, S., Gao, H., Yu, F., Zhang, X., Wang, M., Chen, L., et al. (2023) · Journal of Diabetes Research

Chronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies

Cited by 8